07.28.2018 Issue 133

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Director Global Outcomes Research

Are you looking for a patient-focused company that will inspire you and support your career? If so, be empowered to take charge of your future at Takeda. Join us as an Director Global Outcomes Research in our Cambridge office.

Chief Scientific Officer

Real-World Evidence Project Coordinator – London, UK

Watson Health - Global Product Marketing Leader, Market Access

Data Analyst II - Real-World Evidence - Flexible Location

Executive Director/Senior Research Leader — RWE

Associate Health Economist

Health Economist

Associate Systematic Reviewer

Systematic Reviewer

HealthEconomics.Com, Scientist.Com Partner on RWE/HEOR Initiative

Article: Value-Based Models Offer Near- and Long-Term Opportunities

Merck Avoids Lowering Cost of Blockbuster Products

Is Trump’s Fight Against Drug Prices Gaining Steam?

Novartis CEO Announces Freeze on Price Hikes

GHG's Gorman Talks Medicare Star Ratings, Value

Engelberg: Taxpayers Deserve Reasonable Drug Prices for Federally-Funded Drug Development

Report Spotlights ICER Analysis on Vertex’s CF Drugs

Industry Spotlight

Conferences Webinars
14th Annual Publication Planning
    August 14-15, Philadelphia, Pennsylvania

6th Annual Reimbursement and Access
    August 15-16, Philadelphia, Pennsylvania

World Congress on Biosensors and Bioelectronics
    August 20-21, Chicago, Illinois

340B Manufacturer Summit
    August 21-22, Washington, D.C.

Industry Perceptions and Expectations: The Role of ICER as an Independent HTA
    July 31

Partner With Patients to Achieve Value-Based Pricing
    August 2

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

KAM Metrics: Driving Efficiency, Measuring Success

Biosimilars: E.U. Payer Perspectives

MSL Teams: Field Force Size and Structure

A Guide to Getting Started in HEOR/Market Access Medical Writing

Impact of Displaying in-EHR Patient Drug Prices With or Without Patient Savings Messages

Taking a Total View: Linking Pharmacy + Medical Drug Trends

Reinventing Claims Payment for a Value-Based World

Payers that Engage Members See Better Health Outcomes, Savvier Spending

Seeing the Value and Transparency of Medicare Part B

Special Thanks to Our Partners:
   Evidera    G&J Lee RecruitmentHealthCoreMAPSUniversity of FL
              Truven    XcendaOM1Parexel   Jefferson
      Dymaxium        Precision Xtract    Pharmerit    eMax Health
SciformixEvidence PartnersICON